Juvenile nasopharyngeal angiofibroma (JNA) is a rare, benign but locally aggressive vascular tumor occurring in adolescent males. It originates from the sphenopalatine foramen region (medial wall of the pterygopalatine fossa) and may extend to the nasopharynx, paranasal sinuses, orbit, and intracranial region. It constitutes 0.5% of all head and neck tumors but is the most common nasopharyngeal mass in adolescent males. Clinical triad: unilateral nasal obstruction + recurrent epistaxis + nasopharyngeal mass. The tumor has a very dense vascular structure and shows intense enhancement on CT/MRI. Pterygopalatine fossa widening (Holman-Miller sign) is pathognomonic. Preoperative embolization + surgery is the standard treatment. Biopsy is contraindicated — diagnosis is made by imaging findings due to massive hemorrhage risk.
Age Range
10-25
Peak Age
15
Gender
Equal
Prevalence
Rare
JNA originates from the periosteum and fibrous tissue of the sphenopalatine foramen region — this area is the anatomic junction between the nasal cavity, nasopharynx, and pterygopalatine fossa. The tumor is testosterone-sensitive due to androgen receptor expression and shows rapid growth during puberty — this hormonal dependency explains why the tumor occurs almost exclusively in adolescent males. Histologically, it consists of a mixture of irregular and thin-walled blood vessels (smooth muscle layer absent or incomplete) with dense fibrous stroma. The smooth muscle deficiency in vessel walls explains the inability of vessels to vasoconstrict and the uncontrollability of bleeding — hence biopsy carries massive hemorrhage risk. The intense vascularity of the tumor manifests as very intense enhancement on CT and MRI. Pterygopalatine fossa widening (Holman-Miller sign) results from the tumor filling this narrow anatomic space causing bone remodeling. Intracranial extension usually occurs through the superior orbital fissure or foramen rotundum.
The Holman-Miller sign, the pathognomonic finding of JNA, is the widening of the pterygopalatine fossa by the tumor and anterior bowing of the posterior wall of the maxillary sinus. This finding confirms the sphenopalatine foramen origin of the tumor and largely makes the diagnosis of JNA together with clinical context (adolescent male, epistaxis). Pterygopalatine fossa widening is the earliest and most reliable CT finding of JNA.
On contrast-enhanced CT, JNA shows very intense and homogeneous enhancement — the degree of enhancement approaches vascular structures and reflects the hypervascular nature of the tumor. The mass extends from the nasopharynx to the pterygopalatine fossa, nasal cavity, and paranasal sinuses. Intense enhancement begins in the early arterial phase and continues in late phases (persistent enhancement). Enhancement is homogeneous — necrosis or calcification is rarely seen. Feeding arteries of the tumor (internal maxillary artery branches — especially sphenopalatine artery) may be seen enlarged. On pre-contrast (non-contrast) CT, the mass is isodense to muscle (40-60 HU).
Report Sentence
A solid mass in the nasopharynx/pterygopalatine fossa demonstrates very intense and homogeneous enhancement approaching vascular structure intensity on contrast-enhanced examination; consistent with hypervascular tumor (JNA).
Holman-Miller sign on bone window CT — anterior bowing and widening of the pterygopalatine fossa — is the pathognomonic finding of JNA. The tumor extends from the sphenopalatine foramen into the pterygopalatine fossa, pushing the walls of this narrow anatomic region and causing bone remodeling. The posterior wall of the maxillary sinus (anterior wall of PPF) is pushed forward and bowed. Vidian canal widening is also common in JNA and indicates posterior extension. Foramen rotundum widening suggests extension to the middle cranial fossa. All these bone changes are 'pressure remodeling' type — not aggressive bone destruction.
Report Sentence
Widening of the pterygopalatine fossa and anterior bowing of the posterior wall of the maxillary sinus (Holman-Miller sign) are observed; this finding is pathognomonic for juvenile nasopharyngeal angiofibroma originating from the sphenopalatine foramen.
On T2-weighted sequences, JNA shows heterogeneous signal with numerous flow voids (signal gaps) within the tumor. Flow voids represent the high-flow rapid vascular structures of the tumor and appear as punctate or serpiginous low-signal areas. 'Salt and pepper' pattern — scattered hypointense dots (flow voids) within T2 hyperintense solid component (fibrous stroma) — is quite specific to JNA. These signal characteristics demonstrate the hypervascular structure of the tumor non-invasively and eliminate the need for biopsy. The T2 hyperintense component reflects the free water content of fibrous stroma.
Report Sentence
The mass shows heterogeneous signal on T2-weighted sequences with numerous flow voids (signal gaps) distributed throughout the tumor; this 'salt and pepper' pattern is consistent with hypervascular tumor (JNA).
On T1-weighted sequences, JNA shows isointense or mildly hypointense signal compared to muscle. Flow voids are also seen as low signal areas on T1. On post-contrast T1 fat-sat sequences, very intense and homogeneous enhancement is observed — enhancement degree parallels CT and confirms hypervascular structure. MR angiography (MRA) provides additional information for mapping the tumor's vascular supply and demonstrating feeding arteries. Dynamic contrast-enhanced MR perfusion shows early arterial wash-in. Intracranial extension (dura, cavernous sinus, pituitary fossa) is best evaluated on post-contrast T1 fat-sat MRI.
Report Sentence
The mass shows isointense signal to muscle on T1-weighted sequences with very intense homogeneous enhancement on post-contrast sequences; dense feeding from internal maxillary artery branches is detected on MRA.
On non-contrast CT, JNA appears as a nasopharyngeal mass isodense to muscle (40-60 HU). The extension pattern of the tumor is critical for diagnosis: starting from the sphenopalatine foramen origin, it may extend to the nasopharynx, nasal cavity, pterygopalatine fossa, infratemporal fossa, sphenoid sinus, orbit, and intracranial space. Radkowski staging system is based on this extension pattern. Staging determines surgical planning. Infratemporal fossa involvement indicates lateral extension, sphenoid sinus involvement posterior extension, orbital involvement superior extension. Intracranial extension (Stage IIIA-B) usually occurs through the foramen rotundum, superior orbital fissure, or vidian canal.
Report Sentence
A soft tissue mass originating from the nasopharynx/sphenopalatine foramen region, filling the pterygopalatine fossa and extending to __ is observed; the extension pattern is consistent with JNA (Radkowski Stage __).
JNA shows variable diffusion characteristics on DWI. The fibrous component may show mild-moderate diffusion restriction, but ADC values are generally higher than malignant tumors (1.0-1.5 × 10⁻³ mm²/s). Dense vascular areas may produce false high signal on DWI due to perfusion effect (IVIM effect — intravoxel incoherent motion). Flow voids also appear as low signal on DWI. DWI is not primary for JNA diagnosis but ADC values may help differentiate from malignant tumors — JNA's ADC is generally higher than SCC and lymphoma.
Report Sentence
The mass shows mild-moderate diffusion restriction on DWI (ADC: ~__ × 10⁻³ mm²/s) with no signal in flow void areas; ADC values are higher than malignant tumors and consistent with JNA.
Criteria
Tumor is limited to nasal cavity and/or nasopharynx. IA: Limited to nasal cavity or nasopharynx. IB: Nasal cavity + nasopharynx involvement, paranasal sinus expansion. Minimal or no pterygopalatine fossa involvement. Surgery is usually successful with endoscopic approach.
Distinct Features
Small size, limited extension, low recurrence rate. Holman-Miller sign minimal or absent. Endoscopic excision usually sufficient. Preoperative embolization still recommended.
Criteria
IIA: Maxillary sinus involvement. IIB: Complete involvement of pterygopalatine fossa. IIC: Infratemporal fossa or orbital extension (without bone erosion). Holman-Miller sign is prominent. Surgery is more complex — open or combined approach may be needed.
Distinct Features
Pterygopalatine fossa widening prominent (classic Holman-Miller sign). Vidian canal widening may be present. Preoperative embolization mandatory. Surgical approach planned based on lesion size and extension.
Criteria
IIIA: Middle cranial fossa erosion — minimal intracranial extension. IIIB: Complete invasion of middle cranial fossa or posterior fossa extension. Cavernous sinus involvement. Intracranial extension is a poor prognostic factor. Combined transcranial-transfacial surgery or radiotherapy may be needed.
Distinct Features
Intracranial invasion with bone erosion. Foramen rotundum and/or superior orbital fissure widening. Cavernous sinus involvement shows tumor around ICA. MRI demonstrates intracranial extension better than CT. High recurrence rate, aggressive treatment needed.
Distinguishing Feature
SCC shows aggressive bone destruction, heterogeneous enhancement and necrosis — JNA shows homogeneous intense enhancement, bone remodeling (not destruction). SCC is common in older adults, JNA is specific to adolescent males. No flow voids in SCC, numerous flow voids in JNA. Pterygopalatine fossa widening is specific to JNA.
Distinguishing Feature
Lymphoma shows low T2 signal (high cellularity), very low ADC on DWI, and bone preservation — JNA shows flow voids on T2, intense enhancement, and pterygopalatine fossa widening. Lymphoma is a homogeneous soft tissue mass, JNA is a hypervascular mass. Lymphoma occurs at any age and gender, JNA is specific to adolescent males.
Distinguishing Feature
Inverted papilloma shows cerebriform enhancement pattern (striped/convoluted pattern) — JNA shows homogeneous intense enhancement and flow voids. Inverted papilloma originates from lateral nasal wall, JNA from sphenopalatine foramen. Inverted papilloma is common in middle-aged adults, JNA in adolescent males. No pterygopalatine fossa widening in inverted papilloma.
Urgency
urgentManagement
surgicalBiopsy
Not NeededFollow-up
Post-surgical MRI at 3, 6, and 12 months, then annually for 5 years. MRI preferred over CT for follow-up (no radiation, better soft tissue contrast). Recurrence rate 15-20% overall, higher in advanced stages. Residual/recurrent disease on MRI: enhanced tissue in surgical bed.JNA diagnosis is made by imaging findings + clinical context (adolescent male + epistaxis) — BIOPSY IS CONTRAINDICATED (massive hemorrhage risk, tumor vessels cannot vasoconstrict). Standard treatment: preoperative embolization (internal maxillary artery branches — 24-48 hours prior) + surgical excision. Endoscopic approach is preferred for Stage I-II; open or combined approach for advanced stages. Radiotherapy is an alternative when surgery is not feasible or for residual/recurrent disease — but used cautiously due to secondary malignancy risk. Hormonal therapy (flutamide, testosterone blockade) is in experimental stage. Spontaneous regression is rare and associated with decreased androgen levels after puberty.
JNA is one of the rare tumors that can be diagnosed clinically + imaging without biopsy. Preoperative embolization + surgical resection is standard treatment. Radiotherapy is applied for advanced or inoperable cases. Recurrence rate is 15-20%.